⌘K

Home/Filings/4/A/0001161697-20-000057

4/A//SEC Filing

Bosua Phillip 4/A

Accession 0001161697-20-000057

CIK 0001074828other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 9:00 AM ET

Size

7.8 KB

Accession

0001161697-20-000057

Insider Transaction Report

Form 4/AAmended

Period: 2020-01-01

KNOW LABS, INC.KNWN

DirectorCEO and President10% Owner

Transactions

Award
Common Stock
2020-01-01$1.90/sh+150,000$285,000→ 3,005,000 total

Holdings

Option to Purchase Common Stock
Exercise: $1.28Exp: 2023-08-01→ Common Stock (1,000,000 underlying)
1,000,000
Option to Purchase Common Stock
Exercise: $1.10Exp: 2024-11-04→ Common Stock (1,200,000 underlying)
2,200,000

Footnotes (2)

[F1]Option shares vest 25% quarterly over four years beginning 08/01/2018.
[F2]Option shares vest upon approval of the Company's blood glucose measurement technology by the U.S. Food and Drug Administration.

Documents

1 file

4
form_4.xml
FORM 4/A AMENDMENT NO. 1 FOR 01-01-2020

Issuer

KNOW LABS, INC.

CIK 0001074828

Entity typeother

Related Parties

1

filerCIK 0001738153

Filing Metadata

Form type: 4/A
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 9:00 AM ET
Size: 7.8 KB

View on SEC.gov